MetabolismO-glucuronidation is the major metabolic elimination pathway, mainly by UGT1A9 and UGT2B4 to 2 inactive O-glucuronide metabolitesCYP3A4-mediated (oxidative) metabolism is minimal (~7%)EliminationHalf-life: 10.6 hr (100 mg dose); 13.1 hr (300 mg dose)Total body clearance: 192 mL/minExcretionFeces: 41.5% (canagliflozin), 7% (hydroxylated metabolite), 3.2% (O-glucuronide metabolite)Urine: 33% excreted in urine, mainly as O-glucuronide metabolites (30.5%); <1% excreted unchangedMetabolismO-glucuronidation is the major metabolic elimination pathway, mainly by UGT1A9 and UGT2B4 to 2 inactive O-glucuronide metabolitesCYP3A4-mediated (oxidative) metabolism is minimal (~7%)EliminationHalf-life: 10.6 hr (100 mg dose); 13.1 hr (300 mg dose)Total body clearance: 192 mL/minExcretionFeces: 41.5% (canagliflozin), 7% (hydroxylated metabolite), 3.2% (O-glucuronide metabolite)Urine: 33% excreted in urine, mainly as O-glucuronide metabolites (30.5%); <1% excreted unchangedMetabolismO-glucuronidation is the major metabolic elimination pathway, mainly by UGT1A9 and UGT2B4 to 2 inactive O-glucuronide metabolitesCYP3A4-mediated (oxidative) metabolism is minimal (~7%)EliminationHalf-life: 10.6 hr (100 mg dose); 13.1 hr (300 mg dose)Total body clearance: 192 mL/minExcretionFeces: 41.5% (canagliflozin), 7% (hydroxylated metabolite), 3.2% (O-glucuronide metabolite)Urine: 33% excreted in urine, mainly as O-glucuronide metabolites (30.5%); <1% excreted unchanged
การแปล กรุณารอสักครู่..
